Elevated FGF21 levels after total pancreatectomy and in response to single-dose glucagon receptor antagonist administration in humans

被引：0
|
作者：
Grondahl, M. F. G. [1 ]
Juel, C. T. B. [1 ]
Lund, A. B. [1 ]
Haedersdal, S. [1 ]
Andersen, M. M. [1 ]
Hansen, C. P. [2 ]
Storkholm, J. H. [2 ]
Gillum, M. P. [3 ,4 ]
Hartmann, B. [3 ,4 ]
Holst, J. J. [3 ,4 ]
Vilsboll, T. [1 ,5 ]
Knop, F. K. [1 ,5 ]
机构：
[1] Ctr Clin Metab Res, Hellerup, Denmark
[2] Copenhagen Univ Hosp, Dept Surg, Rigshosp, Copenhagen, Denmark
[3] Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth & Med Sci, Copenhagen, Denmark
[4] Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark
[5] Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
499
引用
收藏
页码：S253 / S253
页数：1
相关论文
共 39 条
  • [21] Subcutaneous Administration of the Novel Somatostatin Receptor 2 Antagonist ZT-01 Restores the Glucagon Response to Hypoglycemia in STZ-Diabetic Rats to Normal Levels
    Farhat, Rawad
    Simonson, Eric
    Riddell, Michael
    Liggins, Richard
    Chan, Owen
    DIABETES, 2020, 69
  • [22] Serum levels of the cold stress hormones FGF21 and GDF-15 after cardiac arrest in infants and children enrolled in single center therapeutic hypothermia clinical trials
    Herrmann, Jeremy R.
    Fink, Ericka L.
    Fabio, Anthony
    Au, Alicia K.
    Berger, Rachel P.
    Janesko-Feldman, Keri
    Clark, Robert S. B.
    Kochanek, Patrick M.
    Jackson, Travis C.
    RESUSCITATION, 2022, 172 : 173 - 180
  • [23] Clinical pharmacology of the dual orexin receptor antagonist ACT-541468 in elderly subjects: Exploration of pharmacokinetics, pharmacodynamics and tolerability following single-dose morning and repeated-dose evening administration
    Muehlan, Clemens
    Boehler, Margaux
    Brooks, Sander
    Zuiker, Rob
    van Gerven, Joop
    Dingemanse, Jasper
    JOURNAL OF PSYCHOPHARMACOLOGY, 2020, 34 (03) : 326 - 335
  • [24] PHARMACOKINETICS AND BIOCHEMICAL EFFICACY AFTER SINGLE AND MULTIPLE ORAL-ADMINISTRATION OF LOSARTAN, AN ORALLY ACTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN HUMANS
    OHTAWA, M
    TAKAYAMA, F
    SAITOH, K
    YOSHINAGA, T
    NAKASHIMA, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 35 (03) : 290 - 297
  • [25] Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed meal
    Zhong Chen
    Xiaoying Fu
    Jian Kuang
    Ju Chen
    Hongmei Chen
    Jianhao Pei
    Huazhang Yang
    BMC Endocrine Disorders, 16
  • [26] Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed meal
    Chen, Zhong
    Fu, Xiaoying
    Kuang, Jian
    Chen, Ju
    Chen, Hongmei
    Pei, Jianhao
    Yang, Huazhang
    BMC ENDOCRINE DISORDERS, 2016, 16
  • [27] Higher bioavailability of magnesium citrate as compared to magnesium oxide shown by evaluation of urinary excretion and serum levels after single-dose administration in a randomized cross-over study
    Kappeler D.
    Heimbeck I.
    Herpich C.
    Naue N.
    Höfler J.
    Timmer W.
    Michalke B.
    BMC Nutrition, 3 (1)
  • [28] EFFECT OF HEXOBENDINE AND INSULIN ON BLOOD GLUCOSE LEVEL AND ON PLASMA LEVELS OF FREE FATTY ACIDS AND CHOLESTEROL IN ALLOXAN-DIABETIC DOGS AFTER SINGLE-DOSE AND LONG-TERM ADMINISTRATION
    KRAUPP, O
    CHIRIKDJIAN, JJ
    NELL, G
    NIESSNER, H
    SPRINGER, A
    PLANK, B
    ARZNEIMITTEL-FORSCHUNG, 1969, 19 (10): : 1684 - +
  • [29] Event-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4-10 and desacetyl-α-melanocyte stimulating hormone
    Smolnik, R
    Perras, B
    Mölle, M
    Fehm, H
    Born, J
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (04) : 445 - 454
  • [30] Inhibition of platelet aggregation after subcutaneous administration of a single-dose of selatogrel, a novel P2Y12 antagonist, in acute myocardial infarction: a randomised open-label phase 2 study
    Sinnaeve, P. R.
    Fahrni, G.
    Schelfaut, D.
    Spirito, A. S.
    Mueller, C. H.
    Frenoux, J. -M.
    Hmissi, A.
    Bernaud, C.
    Moccetti, T.
    Atar, S. A.
    Valgimigli, M. V.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3133 - 3133
1234